| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Donghee Kim | Q45970203 |
| Aijaz Ahmed | Q47168895 | ||
| George Cholankeril | Q59749426 | ||
| Umair Iqbal | Q88586046 | ||
| Brittany B Dennis | Q123569390 | ||
| P2093 | author name string | Muhammad Ali Khan | |
| Andrew A Li | |||
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860606 |
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Early and late effects of low-dose aspirin on renal function in elderly patients | Q28165684 | ||
| Current status of novel antifibrotic therapies in patients with chronic liver disease | Q30473375 | ||
| Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. | Q36167647 | ||
| Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis | Q36393781 | ||
| Therapy for fibrotic diseases: nearing the starting line | Q38072881 | ||
| Treatment of Patients with Cirrhosis | Q38936166 | ||
| Aspirin use is associated with lower indices of liver fibrosis among adults in the United States. | Q40124752 | ||
| Effects of acetyl salycilic acid and ibuprofen in chronic liver damage induced by CCl4. | Q40332441 | ||
| Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation. | Q42199539 | ||
| Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases. | Q46079573 | ||
| Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease | Q46506089 | ||
| Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients | Q50276497 | ||
| Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice. | Q53024107 | ||
| Prevention by acetylsalicylic acid of liver cirrhosis and carcinogenesis as well as generations of 8-hydroxydeoxyguanosine and thiobarbituric acid-reactive substances caused by a choline-deficient, L-amino acid-defined diet in rats. | Q53471877 | ||
| Utilization of aspirin and statin in management of coronary artery disease in patients with cirrhosis undergoing liver transplant evaluation | Q58217904 | ||
| Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 1. Morphology and inhibition of fibrogenesis by dipyridamole | Q71650829 | ||
| Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis | Q84432107 | ||
| Use of Antiplatelet Agents Is Inversely Associated With Liver Fibrosis in Patients With Cardiovascular Disease | Q90575091 | ||
| P433 | issue | 1 | |
| P921 | main subject | chronic liver disease | Q5113984 |
| P304 | page(s) | 84-90 | |
| P577 | publication date | 2018-12-12 | |
| P1433 | published in | Hepatology international | Q26842730 |
| P1476 | title | Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis | |
| P478 | volume | 13 |
Search more.